Qiming Venture Partners

Armo BioSciences adds Stella Xu and Min Cui to Board along with raising $67m Series C-1 financing led by Qiming Venture Partners

– USA, CA – ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced the successful completion of a $67 million Series C-1 private financing led by new investor Qiming Venture Partners.… => Read more

Connect Biopharmaceuticals adds Drs William Hu and Xiaoping Ye to Board along with raising $20m Series A financing led by Qiming Venture Partners

– CHINA, Taicang – Connect Biopharmaceuticals, Ltd., a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and cancer, today announces the completion of a $20 million Series A financing.… => Read more